ALK and cancer: ALK gene copy number gains (3−5 copies/cell), especially ALK gene amplification (>6 copies/cell and/or clusters of signals) (Figure 3) are well studied in other types of cancer, i.e., neuroblastoma, and are generally considered to be associated with aggressive tumor behavior and poorer outcomes [73].